Contemporary Evaluation and Management of Diabetic Cystopathy

被引:0
|
作者
Al Taweel W. [1 ]
机构
[1] Department of Urology, King Faisal Specialist Hospital and Research Centre, Alfaisal University, PO Box 3354, Riyadh
关键词
Complications; Diabetes mellitus; Diabetic cystopathy; Overactive bladder; Quality of life; Urinary incontinence; Voiding dysfunction;
D O I
10.1007/s11884-013-0175-x
中图分类号
学科分类号
摘要
The M(3) receptor (M(3)-mAChR) is the major muscarinic subtype in the animal bladder responsible for detrusor contraction. The alterations in its protein quantity and biosynthesis during diabetic cystopathy were investigated. Three-month-old male Wistar rats were divided into two groups: (1) 2-week diabetic rats and (2) normoglycemic control rats. Diabetes was induced by a single intravenous injection of 60 mg/kg streptozotocin. The amount of M(3) receptor protein in the rat bladder body tissue was measured by Western immunoblotting using monoclonal antibodies. For determination of M(3) muscarinic receptor mRNA in the bladder tissue, the method of Northern blotting was employed. The results of the Western immunoblotting showed that the amount of M(3)-mAChR protein in the diabetic bladder was significantly increased by about 70.2 +/- 8.5 % when compared to the control bladder (p < 0.05, n = 8). Northern blotting demonstrated a 54.7 +/- 6.0 % increase of M(3)-mAChR mRNA in the diabetic bladder (p < 0.05, n = 8). The findings of the present study demonstrated an upregulation of M(3)-mAChR biosynthesis in the diabetic urinary bladder. This phenomenon offers an explanation of the increased contractility after muscarinic stimulation of the detrusor muscle of diabetic animals in human diabetic cystopathy as clasically described consists of triad of decreased bladder sensation, increased capacity and impaired detrusor contractility; however it is now clear that significant number of patients will have overactive bladder. High clinical suspicion and referal for urodynamics will allow improved diagnosis and treatment of bladder dysfunction. © 2013 Springer Science+Business Media New York.
引用
收藏
页码:77 / 82
页数:5
相关论文
共 50 条
  • [1] Diabetic cystopathy
    Siracusano, S
    d'Aloia, G
    Lentini, MG
    Silvestre, G
    DIABETES NUTRITION & METABOLISM, 2002, 15 (01) : 41 - 44
  • [2] Diabetic cystopathy
    Nanigian D.K.
    Keegan K.A.
    Stone A.R.
    Current Bladder Dysfunction Reports, 2007, 2 (4) : 197 - 202
  • [3] Contemporary Evaluation and Management of the Diabetic Foot
    Sumpio, Bauer E.
    SCIENTIFICA, 2012, 2012
  • [4] Diabetic cystopathy: A review
    Yuan, Zhengyong
    Tang, Ziwei
    He, Changxiao
    Tang, Wei
    JOURNAL OF DIABETES, 2015, 7 (04) : 442 - 447
  • [5] TREATMENT OF DIABETIC CYSTOPATHY
    FRIMODTMOLLER, C
    MORTENSEN, S
    ANNALS OF INTERNAL MEDICINE, 1980, 92 (02) : 327 - 328
  • [6] Diabetic Cystopathy with Bilateral Hydronephrosis
    Schulman, Jacqueline M.
    Gelber, Allan C.
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (06): : E255 - E256
  • [7] CYSTOPATHY COMPLICATING DIABETIC NEPHROPATHY
    FRIEDMAN, EA
    LAUNGANI, G
    COHEN, L
    BUTT, KMH
    KIDNEY INTERNATIONAL, 1985, 27 (01) : 138 - 138
  • [8] Diabetic urethropathy compounds the effects of diabetic cystopathy
    Yang, Zhongguang
    Dolber, Paul C.
    Fraser, Matthew O.
    JOURNAL OF UROLOGY, 2007, 178 (05): : 2213 - 2219
  • [9] DIABETIC CYSTOPATHY - EPIDEMIOLOGY AND RELATED DISORDERS
    FRIMODTMOLLER, C
    ANNALS OF INTERNAL MEDICINE, 1980, 92 (02) : 318 - 321
  • [10] FUNCTIONAL AND STRUCTURAL ASPECTS OF DIABETIC CYSTOPATHY
    EIKA, B
    DANISH MEDICAL BULLETIN, 1994, 41 (04): : 445 - 445